Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0085-2027

BARD EP XT DECAPOLAR STEERABLE, DIAGNOSTIC EP CATHETER, 6F, LARGE 4.0, 10, 2-5-2MM, REF: 201007 Recall

BARD EP XT DECAPOLAR STEERABLE, DIAGNOSTIC EP CATHETER, 6F, LARGE 4.0, 10, 2-5-2MM, REF: 201007

FDA recall Class II

Ongoing

FDA lists this Class II recall for BARD EP XT DECAPOLAR STEERABLE, DIAGNOSTIC EP CATHETER, 6F, LARGE 4.0, 10, 2-5-2MM, REF: 201007. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0085-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 18, 2026
FDA report date
Oct 14, 2026
Quantity in commerce
10
Distribution
See key details
FDA cause
Packaging process control

What is being recalled?

BARD EP XT DECAPOLAR STEERABLE, DIAGNOSTIC EP CATHETER, 6F, LARGE 4.0, 10, 2-5-2MM, REF: 201007

Affected model & UDI checker

Search the exact identifiers published for Z-0085-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
201007BARD EP XT DECAPOLAR STEERABLE, DIAGNOSTIC EP CATHETER, 6F, LARGE 4.0, 10, 2-5-2MM, REF: 201007Check source noticeNot specified
Not specifiedBARD EP XT DECAPOLAR STEERABLE, DIAGNOSTIC EP CATHETER, 6F, LARGE 4.0, 10, 2-5-2MM, REF: 201007Check source notice00885825003838
FDA code information

UDI-DI: 00885825003838. Lot: 5640704, Serial: 5097742, Distribution Date: May 26th 2026

View the original FDA recall notice

Why was this product recalled?

Diagnostic electrophysiology (EP) catheter may have a breached sterile barrier on the straight seal side of the primary pouch, which if used could lead to particulate embolization, infection, thrombus or ganuloma formation from particulate matter.

What actions did Stryker Sustainability Solutions take?

On 8/18/2026, the recall notice was mailed to the customer asking them to do the following: 1) Inform individuals within your organization who need to be aware of this action. 2) Quarantine and return affected product to the firm. 4) Complete and return the Business Reply Form via email to SSSPFA@stryker.com Questions can be directed to the firm via email, SSSPFA@stryker.com, or via phone 800-624-4422.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology